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Abstract
Enteroviruses often cause mild disease, yet are also linked to development of autoimmune
diabetes. Dendritic cells (DCs) shape both innate and adaptive immune responses, includ-
ing anti-viral responses. How different human DC subsets shape anti-viral responses,
whether they have complementary or overlapping functions and how this relates to autoim-
mune responses is largely unknown. We used enterovirus-infected β-cells and freshly iso-
lated human myeloid DC (mDC) subsets as a model for autoimmune type 1 diabetes. Our
data show that both the BDCA1+ and BDCA3+ mDC subsets engulf mock- as well as virus-
infected β-cells, albeit BDCA1+ mDCs are more efficient. Uptake of enterovirus-infected,
but not mock-infected cells, activated both DC subsets as indicated by the induction of co-
stimulatory molecules and secretion of type I and type III interferons. Both subsets produced
similar amounts of interferon-α, yet the BDCA3+ DC were superior in IFN-λ production. The
BDCA1+ mDCs more strongly upregulated PD-L1, and were superior in IL-12 and IL-10 pro-
duction as compared to the BDCA3+ DC. Despite lack of IL-12 production by the BDCA3+
DC, both BDCA1+ and BDCA3+ DCs activated T cells in allogeneic mixed lymphocyte reac-
tion towards a Th1-type reactivity while suppressing Th2-associated cytokines.
Introduction
The immunopathology for many autoimmune disorders remains unclear, but infections in
general and viral infections in particular have been hypothesized to accelerate or even trigger
autoimmune diseases [1–5]. Viruses can directly infect and kill target cells, or alternatively, can
induce inflammation and autoimmunity through indirect immune mechanisms e.g. via by-
stander immune activation [6, 7]. Antigen-presenting dendritic cells (DCs) are key modulators
of immune homeostasis and induce immune responses against pathogens while maintaining
tolerance to self to prevent autoimmunity [8, 9]. Here, we study early DC immune activation
upon encounter with virus-infected β-cells using fresh human myeloid DCs (mDCs) instead of
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the monocyte-derived DCs generated in vitro. This setting better mimics the physiological situ-
ation during enterovirus infections and may resemble the situation during type 1 diabetes path-
ogenesis. We used coxsackie B3 virus (CVB3), an enterovirus belonging to the human
enterovirus B (HEV-B) viruses which are associated with type 1 diabetes development [5, 6,
10]. HEV-B viruses are small RNA viruses that usually cause mild or asymptomatic infections
in the gastrointestinal tract, yet severe infections can occur resulting in e.g. myocarditis or en-
cephalitis. Furthermore, HEV-Bs have been associated with chronic autoimmune diseases such
as type 1 diabetes and myocarditis [5, 11] and, importantly, they have a tropism for islets of
Langerhans [12–14].
Dendritic cells (DCs) shape both the innate and adaptive immune responses, and as such
are implicated in the pathogenesis of most autoimmune diseases [8]. Furthermore antigen-
presenting cells (APCs) such as DCs are critical during the induction of virus-induced autoim-
munity [15]. Moreover, differences in DC-number and function have been reported between
type 1 diabetes-patients and healthy donors [16–20], although some studies contradict each
other indicating that further research is required. In order to respond adequately DCs sample
their microenvironment and phagocytose foreign material as well as apoptotic and necrotic
cells [21]. DCs express specialized receptors known as pattern recognition receptors (PRRs)
which bind pathogen-associated molecular patterns (PAMPs). Upon triggering of these recep-
tors the DCs become activated and initiate immune responses [22]. DCs modulate innate im-
munity, e.g. via the production of type I interferons (IFNs), as well as adaptive immune
responses, e.g. by antigen presentation, costimulation and production of cytokines and chemo-
kines which results in activation and skewing of (naïve) T and B cells. Most knowledge on
human DC function originates from studies using monocyte-derived DCs; however, these in
vitro differentiated DCs differ markedly from naturally occurring DCs [22–24].
In recent years 2 subsets of naturally occurring human blood derived myeloid DCs (mDCs)
have been described, BDCA1+/CD1c+ mDCs and BDCA3+/CD141+ mDCs [25]. These subsets
differ in their expression of cell surface markers, Toll-like receptors (TLRs) and other PRRs,
such as RIG-I-like receptors [25–28]. The BDCA3+ mDCs are reported to be more efficient in
cross-presenting antigen to CD8+ cytotoxic T lymphocytes (CTLs) compared to BDCA1+
mDCs [27, 29–31]. Only few functional studies on responses of human BDCA1+ and BDCA3+
DCs have been published due to the low frequency of these cells in human blood (BDCA1+
and BDCA3+ DCs resemble approximately 0.3–1% and 0.04% of human peripheral blood
mononuclear cells (PBMCs)). Studies so far mainly focused on the response upon stimulation
with a high amount of isolated TLR-ligands [28–30], a situation that does not well resemble
physiological conditions where infected and damaged cells are encountered by DCs. We stud-
ied the response of BDCA1+ and BDCA3+ mDC subsets from healthy donors upon encounter
of enterovirus-infected cells to determine overlapping and complementary functions and dis-
cuss possible implications for induction of autoimmune reactions.
Our data show that although BDCA1+ and BDCA3+ mDC subsets have distinct response
patterns upon exposure to enterovirus-infected β-cells, they both promote Th1 responses that
could favor the induction or maintenance of β-cell autoimmune reactivity.
Materials and Methods
Ethics Statement
Buffycoats or leukapheresis products were obtained from healthy volunteers after written con-
sent according to institutional guidelines and the Declaration of Helsinki and were obtained
via Sanquin Blood Bank, Nijmegen, The Netherlands. Blood products were released anon-
ymized to laboratory personnel.
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Isolation and culture of cells
BDCA1+ mDCs were isolated by magnetic-activated cell sorting (MACS) using a BDCA-1 isola-
tion kit, according to the manufacturer’s instructions (Miltenyi Biotec). In short, peripheral
blood mononuclear cells (PBMCs) were isolated from buffy coat/leukapheresis products using a
Ficoll gradient, washed, followed by CD19+ cell-depletion to deplete B cells and subsequently
positively selected for BDCA1+ cells. To obtain peripheral blood leukocytes (PBLs), monocytes
were depleted from PBMCs by adherence to plastic culture flasks. BDCA3+ mDCs were subse-
quently isolated from PBLs by positive selection using a BDCA3+ mDC isolation kit as described
[27]. Cells were routinely up to 95% pure, as assessed by double staining BDCA1-APC/CD11c-
PE (Miltenyi Biotec, and BD Pharmingen, respectively) or BDCA3-APC/CD11c-PE. mDCs
were cultured in X-Vivo 15 (Lonza) supplemented with 5ng/ml GM-CSF (Strahtman) and were
used for experiments immediately after isolation. DCs were cultured 0.3x106 cells in a 24-well
culture plate in 400μl medium, or scaled up or down according to number of cells available.
Min6 insulinoma cells [32] were a gift from dr. Per Bendix Jeppesen and were cultured in
Dulbecco’s modified Eagle’s medium (DMEM)(Gibco) supplemented with 15% FCS, 0.5% an-
tibiotic/antimycotic and 50 μmol/l β-mercaptoethanol (complete DMEM) at 37°C in 5% CO2.
Medium was refreshed every other day.
Virus propagation, purification and infection of β-cells
CVB3 Nancy (CVB3) was kindly provided by R. Kandolf (University of Tübingen, Germany).
Production of virus stocks and virus titrations were performed as described [33]. When used
for flowcytometry purposes, cells were labeled with PKH67 (Sigma Aldrich) prior to infection.
Min6 cells were infected at a multiplicity of infection (MOI) of 15 in complete DMEM [34].
After 1 hour incubation at 37°C cells were washed to remove excess virus and were cultured in
complete DMEM for 48 hours before harvesting the cells for co-culture with human BDCA1+
or BDCA3+ mDCs.
mDC stimulation
mDCs were left unstimulated, or stimulated with poly I:C (Enzo Life Sciences)(20μg/ml), or
were co-cultured in a 1:1 ratio with mock- or CVB3-infected Min6 cells. Alternatively, mDCs
were exposed to CVB3 (MOI of 50) in X-Vivo15. Supernatant and cells were harvested at indi-
cated times for mRNA isolation, flow cytometry or ELISA/bead array, or used in allogeneic
mixed lymphocyte reaction (MLR).
RNA isolation and quantitative PCR (qPCR)
RNA isolations were done using the ZR RNA isolation kit (Zymo Research) and reverse-
transcribed into cDNA as described [35]. Alternatively, total RNA was isolated with RNeasy
MiniPrep Kit (Qiagen Benelux). The optional on-column DNAse treatment was applied. RNA
was transcribed into cDNA with the RT2 First Strand cDNA Kit (SABiosciences, Qiagen Bene-
lux) according to manufacturer’s instructions. mRNA levels for the genes of interest were de-
termined by quantitative PCR (qPCR) with a Biorad CFX apparatus (Biorad) using SYBR
Green (Applied Biosystems). Analysis was done using Biorad CFX-1.6 software. Primer se-
quences are available on request and most are from the Primer Bank database [36].
Flow cytometry
Cells were harvested with cold PBS at indicated time points, washed twice in PBS and stained
with fixable viability dye (eBioscience) for 30 minutes on ice. Subsequently, cells were stained
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as described [33] with conjugated antibodies directed against cell surface markers or corre-
sponding isotypes. CD80-PeCy7, CD86-PeCy7, PD-L1-PE and PD-L2-PE were all from BD
Pharmingen; ICOS-L-PerCP was from R&D systems and B7-H3-Alexa488 and
B7-H4-Alexa488 were from AbD Serotec. In Min6 co-cultures, expression of co-stimulatory
molecules was analyzed on CD11c-APChigh (BD) or BDCA3-APC (Miltenyi) expressing
mDCs for BDCA1 and BDCA3 mDCs, respectively. Cells were analyzed on a CyAn Flow cy-
tometer (Beckman Coulter) and data was analyzed using FlowJo software, gated on living cells.
Pulse width analysis was included to exclude doublets and only analyze single cells. An example
of the gating strategies used is shown in S1 Fig.
Allogeneic MLR
DCs were harvested using cold PBS after overnight (o/n) stimulation and co-cultured with allo-
geneic peripheral blood lymphocytes in a 1:10 DC:PBL ratio using 1x105 PBLs per well in a
96-well U-bottom plate. After 4 days of culture T cell proliferation was assessed by adding
1 μCi/well of tritiated thymidine for 16 hours. Incorporated thymidine was measured in a β-
counter.
ELISA and bead array
IFN-λ1, IL-10 and IL-27 production was analyzed with a human IFN-lambda 1 ELISA (IL-29)
kit, human IL-10 ELISA kit and human IL-27 ELISA kit (all from eBioscience) respectively.
Millipore human 22-plex was used to determine multiple cytokine and chemokine levels pro-
duced (the following cytokines were measured: Flt3-L, Fractalkine, G-CSF, IFNα2, IFNγ, IL-
1α, IL-1β, IL-1ra, IL-6, IL-12p70, IL-13, IL-15, IL-17, IP-10, MCP1, MCP3, MDC, MIP1α,
MIP1β, RANTES, TGFα, TNFα). Data analysis was performed with Bio-Plex Manager soft-
ware (Bio-Rad Laboratories). T helper cell cytokines were determined by 13-plex Th1/Th2/
Th9/Th17 bead array (BenderMed systems).
Statistical analysis
Statistical analysis was performed using ANOVA followed by post-hoc Tukey test as indicated.
A p-value<0.05 was considered significantly different.
Results
Human BDCA1+ and BDCA3+ mDCs phagocytose mock- and CVB-
infected murine insulinoma cells
To investigate whether freshly isolated mDC subsets phagocytose pancreatic β-cells, they were
co-cultured with PKH67-labeled Min6-cells that were mock- or CVB3-infected [34]. During
physiological circumstances DCs will encounter infected cells at different stages of infection.
Therefore, virus-infected cells were infected 48 hours prior to co-culture with DCs. In this set-
ting a heterogeneous population of Min6 insulinoma cells is present showing cytopathic effects
in approximately 80% of the cells (S2 Fig). Mock- and CVB-infected cells were efficiently taken
up by BDCA1+ mDCs, resulting in an average of 50 to 70% of PKH+ BDCA1+ DCs, respective-
ly (Figs. 1A and C). Uptake of CVB-infected cells was somewhat more efficient than uptake of
mock-infected cells, although this did not reach statistical significance (Fig. 1C). BDCA3+
mDCs also engulfed mock-and CVB-infected Min6 material (Figs. 1B and C), although a lower
proportion of BDCA3+ DCs engulfed Min6 material. For example, approximately 70% of
BDCA1+ DCs had engulfed CVB-infected Min6 material after overnight (o/n) co-culture, com-
pared to approximately 30% of BDCA3+ mDCs (Fig. 1C). BDCA3+ DCs that did engulf labeled
DC Subset Responses to CVB-Infected β-Cells
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Min6 material also had a lower mean fluorescent intensity than BDCA1+ mDCs further sug-
gesting uptake by BDCA1+ mDCs is more efficient (Fig. 1B). Confocal analysis confirmed the
uptake of β-cell material by showing the presence of PKH-labeled Min6 material within DCs
(S3 Fig). Thus, both blood mDC subsets can engulf mock- and CVB-infected β-cells, although
BDCA1+ mDCs more efficiently than BDCA3+ mDCs.
BDCA1+ and BDCA3+ mDC produce IFNs after uptake of
CVB3-infected, but not mock-infected β-cells
To study the innate antiviral response of the mDC subsets we assessed the production of IFN-
α2 and IFN-λ1. IFN-α2 was efficiently induced upon co-culture with CVB-infected, but not
mock-infected β-cells in both mDC subsets, and reached similar levels (Fig. 2A, left panel).
Strikingly, upon o/n culture the levels of IFN-α2 induced by virally-infected cells were approxi-
mately 3-fold higher on average compared to stimulation with poly I:C, a double-stranded
RNA mimic which serves as a positive control. IFN-λ1 was also induced in both subsets upon
stimulation with CVB-infected cells and poly I:C, yet BDCA3+ mDCs produced much more
IFN-λ1 compared to BDCA1+ mDCs (3 to 6- fold higher induction, depending on the donor)
Fig 1. BDCA1+ mDCsmore efficiently phagocytose murine Min6 cells compared to BDCA3+ mDCs. A)
BDCA1+ mDCs or B) BDCA3+ mDCs were co-cultured overnight (o/n) with PKH67-labeled mock- or CVB-
infected Min6 cells (M6/M and M6/CVB, respectively) stained for the CD11c or BDCA3 and analyzed by flow
cytometry on viable, single cells (See S1 Fig). Percentages in upper right corner represent the percentage of
DCs that has engulfed Min6 material. This was calculated as follows: percentage PKH+ DCs/total DCs (i.e.
total CD11c positive cells or total BDCA3 positive cells) C) DCs were analyzed as in A) and B), shown is
average + SEM for>3 donors. * p<0.05, *** p<0.001 determined by ANOVA and post-hoc Tukey test.
doi:10.1371/journal.pone.0121670.g001
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(Fig. 2A, right panel). No major differences were observed for IFN-λ1 induction upon stimula-
tion with poly I:C compared to CVB-infected Min6 cells.
Next, we used qPCR to study the induction of IFN-stimulated genes (ISGs) Mda5, RIG-I
and OAS1 6 hours after stimulation. The use of human mRNA-specific primers enabled us to
determine mRNA expression in human mDCs specifically, while not amplifying murine Min6
template. As shown in Fig. 2B, very low basal expression of ISGs Mda5, RIG-I and OAS1 was
detected in unstimulated mDCs (medium, Med), although for all ISGs tested mRNA levels
were higher in unstimulated BDCA3+ DCs than BDCA1+ mDCs. Stimulation with poly I:C for
Fig 2. Type I and type III IFN responses are induced in mDC subsets upon encounter of CVB-infected
cells. A) DCs were co-cultured with mock- or CVB-infected Min6 cells (M6/M or M6/CVB), infected with CVB3
(MOI 50), stimulated with poly I:C, or left unstimulated (medium; Med) and after o/n incubation supernatant
was harvested and analyzed for production of IFN-α2 (left panel) or IFN-λ1 (right panel). Shown are data from
4 (IFN-α2) and 3 (IFN-λ1) different donors.B) DCs were stimulated as in A) and after 6 hours mRNA
expression was analyzed by qPCR. Shown are data from 4 donors (B, corresponding symbols represent the
same donor). * p<0.05, ** p<0.01, *** p<0.001 determined by ANOVA and post-hoc Tukey test.
doi:10.1371/journal.pone.0121670.g002
DC Subset Responses to CVB-Infected β-Cells
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6 hours resulted in major increase of the ISGs tested (Fig. 2B). Six hours co-culture with mock-
infected cells (M6/M) had little effect on ISG-expression, whereas co-culture with CVB3-in-
fected Min6 cells (M6/CVB) resulted in increased ISG expression, and reached comparable lev-
els in BDCA1+ and BDCA3+ mDCs relative to the housekeeping gene GAPDH. For example
Mda5 levels increased 11- to 33-fold over M6/M in BDCA1 mDCs and 2.5- to 7.3-fold in
BDCA3 mDCs, depending on the donor (Fig. 2B). CVB3 is unable to productively infect
BDCA1+ mDCs by direct infection [24], and only induced low ISG levels when high CVB3 ti-
ters (MOI 50) were used. In summary, these data show that type I and type III IFNs, as well as
various ISGs, are efficiently induced in BDCA1+ and BDCA3+ mDCs upon encounter of CVB-
infected, but not mock-infected β-cells.
Uptake of CVB-infected β-cells results in phenotypic DC maturation and
production of various cytokines and chemokines in BDCA1+ and
BDCA3+ mDCs
To investigate whether virus-infected cells induced mDC maturation we analyzed expression
of co-stimulatory and co-inhibitory molecules from the B7 family [37] after o/n co-culture
with Min6 cells. Co-culture with CVB3-infected Min6 cells resulted in significant increase of
co-stimulatory markers CD80, CD86 in both mDC subsets (Fig. 3), as compared to mock-in-
fected Min6 cells. The co-inhibitory marker PD-L1 was specifically induced upon encounter of
CVB-infected cells in BDCA1+, but not BDCA3+ mDCs. Poly I:C, which was used as a positive
control induced CD80, CD86 and PD-L1 to levels comparable to M6/CVB-stimulation.
ICOS-L was expressed at low levels in both BDCA1+ and BDCA3+ mDCs, and expression was
unaltered upon stimulation with mock- or CVB-infected Min6 cells. A modest decrease in
ICOS-L expression was observed in poly I:C-stimulated BDCA3+ mDCs. PD-L2, B7-H3 and
B7-H4 were not expressed, nor induced under any of the conditions tested (Fig. 3). Co-culture
with mock-infected Min6 cells or stimulation with CVB3 (MOI 50) had no or only modest ef-
fects on expression of any of the cell surface markers tested in both mDC subsets (Fig. 3).
Next, we assessed production of a panel of pro-inflammatory cytokines and chemokines in-
duced upon stimulation with poly I:C, mock- or CVB-infected Min6 cells, or CVB3 exposure.
From mock or CVB3-infected Min6 cells alone no cytokines were detected in the human
22-plex, excluding that the observed cytokines are Min6-derived (S4 Fig). TNF-α and IL-6
were induced in both DC subsets upon poly I:C stimulation and co-culture with CVB-infected
Min6 cells, but not mock-infected cells (Fig. 4), although higher levels of TNF-α were produced
by BDCA1+ mDCs compared to BDCA3+ mDCs. IL-12p70 production by BDCA1+ mDCs was
apparent in all donors upon stimulation with CVB-infected Min6 cells. Interestingly, little or
no IL-12p70 was induced in BDCA3+ mDCs under the conditions tested. The anti-inflamma-
tory cytokine IL-10 was induced in BDCA1+ mDCs upon stimulation with M6/CVB, yet like
IL-12 was hardly produced by the BDCA3+ mDCs. Stimulation with poly I:C showed a similar
trend for IL-12 and IL-10 with high levels found in BDCA1+ cultures but hardly any produc-
tion in BDCA3+ cultures (Fig. 4).
Chemokines MIP-1α/CCL3 and MIP-1β/CCL4 were strongly induced in both mDC subsets
upon M6/CVB-stimulation or poly I:C stimulation (Fig. 4), but were induced at much higher
levels in BDCA1+ mDCs relative to BDCA3+ mDCs. For example, MIP-1β/CCL4 was induced
22-fold on average upon stimulation with M6/CVB in BDCA1+ mDCs, compared to a 6-fold
increase in BDCA3+ mDCs. MCP-1/CCL2, MCP-3/CCL7 and IP-10/CXCL10 were highly in-
duced in BDCA1+ mDCs upon poly I:C or M6/CVB stimulation compared to unstimulated
DCs. Again the fold increase was much less for the BDCA3+ cultures, though expression under
unstimulated conditions was higher for BDCA3+ DCs. RANTES/CCL5 was induced to similar
DC Subset Responses to CVB-Infected β-Cells
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extent in both subsets upon stimulation. The chemokine MDC was already produced by both
subsets at unstimulated conditions and remained unaltered after stimulation of BDCA3+
mDCs whereas expression decreased in the BDCA1+ mDCs. In summary, these data indicate
that both mDC subsets become activated upon encounter of CVB-infected Min6 cells, however
the BDCA1+ mDC subset is a more potent producer of most pro-inflammatory and anti-
inflammatory cytokines and chemokines tested.
Fig 3. Phagocytosis of CVB-infected Min6 cells results in upregulation of co-stimulatory markers in BDCA1+ mDC and BDCA3+ mDC, and co-
inhibitory marker PD-L1 in BDCA1+ mDCS. DCs were stimulated o/n as in Fig. 2A and subsequently analyzed for expression of indicated cell surface
markers using flow cytometry. Shown are averages of mean fluorescence intensity (MFI)-isotype values of>3 donors + SEM. * p<0.05, ** p<0.01
determined by ANOVA and post-hoc Tukey test.
doi:10.1371/journal.pone.0121670.g003
DC Subset Responses to CVB-Infected β-Cells
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Fig 4. Cytokine and chemokine production in BDCA1+ and BDCA3+ mDCs upon encounter of mock- or virus-infected cells.DCs were stimulated o/n
as in Fig. 2A and supernatant was analyzed for production of pro-inflammatory cytokines and chemokines. Data represent average of 4 independent
experiments using different donors + SEM. * P<0.05, ** P<0.01, ***p<0.001 comparing M6/CVB versus M6/M or poly I:C versus medium; # p<0.05 Min6/
CVB versus poly I:C; $ p<0.05 in BDCA1+ versus BDCA3+ mDCs with the same stimulus as determined by ANOVA and post-hoc Tukey test.
doi:10.1371/journal.pone.0121670.g004
DC Subset Responses to CVB-Infected β-Cells
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Both BDCA1+ and BDCA3+ mDCs efficiently induce Type 1 and
suppress Type 2 responses upon encounter of CVB-infected β-cells
We compared the capacity of differentially stimulated mDC subsets to induce T cell prolifera-
tion and Type 1 or type 2 responses in allogeneic mixed lymphocyte reactions. Proliferation
was assessed at day 4 and revealed that both DC subsets induce T cell proliferation in MLR in
unstimulated conditions (medium), and that proliferation is not further enhanced upon stimu-
lation with poly I:C, M6/M or M6/CVB (Fig. 5A). T cell cytokine analysis revealed that poly I:
C and M6/CVB stimulated DCs induced production of Type 1 cytokine IFN-γ while simulta-
neously strongly suppressing Type 2 cytokines IL-5 and IL-13 (Fig. 5B). This was corroborated
by qPCR analysis of IFN-γ and IL-5 in BDCA1+ and BDCA3+ MLR samples (S5 Fig). There
were no significant differences in IFN-γ induction capacity between both mDC subsets. No
consistent induction of Th17 cells was observed for BDCA1+ nor BDCA3+ mDCs in allogeneic
MLR under the conditions tested (S6 Fig). These data indicate that BDCA1+ and BDCA3+
mDCs are equally efficient in inducing Type 1 responses upon encounter of enterovirus-in-
fected cells, despite lower uptake capacity of BDCA3+ mDCs and lower production of IL-
12p70.
Besides IL-12, other cytokines are known that may (synergistically) induce Type 1 re-
sponses, such as the IL-12-like cytokine IL-27 [38–40]. We hypothesized that IL-27 may be
produced in larger quantities by BDCA3+ mDCs than BDCA1+ mDCs, thereby facilitating effi-
cient Type 1 induction in BDCA3+ MLR cultures, despite much lower IL-12 production. Both
BDCA1+ and BDCA3+ mDCs strongly expressed IL-27p28 (IL27A) mRNA upon stimulation
with M6/CVB or poly I:C, but not M6/M (Fig. 5C). EBI3 (IL27B) was expressed at higher levels
compared to IL27p28 in unstimulated cultures and expression was unaltered upon stimulation
with M6/M or M6/CVB (S7 Fig). IL-27 ELISA corroborated our findings on IL-27p28 mRNA
induction in BDCA1+ and BDCA3+ mDCs (Fig. 5D). Since IL-27 is equally induced by
BDCA1+ and BDCA3+ mDCs, it is not likely the factor driving Type 1 polarization in BDCA3+
cultures as a substitute of IL-12 in BDCA1+cultures.
Discussion
The precise pathophysiology resulting in T cell activation during autoimmunity development
remains unclear; however, viral infections can trigger the development of autoimmunity [2, 7].
Distinct subsets of mDCs could differentially influence T cell activation upon encounter of
virus-infected cells. However, although mRNA profiling studies predict functional differences
between human BDCA1+ and BDCA3+ mDC, relatively few studies provide experimental evi-
dence for this in response to virus-infected cells. Here, we report on the response of human
BDCA1+ and BDCA3+ mDC to mock- versus CVB-infected β-cells, conditions mimicking the
physiological encounter of virus-infected cells and APCs. Our data show that BDCA1+ mDC
more efficiently engulf mock- or CVB-infected Min6 material compared to BDCA3+ mDCs.
Uptake of virus-infected β-cells resulted in induction of co-stimulatory molecules, production
of type I and III IFNs and ISG-induction. Similar type I IFN secretion was observed in both
mDC subsets, yet BDCA3+ mDCs are superior in IFN-λ production. BDCA1+ mDCs were
more potent inducers of co-inhibitory PD-L1 and produced most pro-inflammatory cytokines
and chemokines, with a striking difference in IL-12p70 and IL-10, which are hardly produced
by BDCA3+ mDCs. Our data indicate that the mDC subsets exhibit distinct response patterns
upon encounter of enterovirus-infected cells, but both promoted Th1 T cell responses in an al-
logeneic MLR.
We observed efficient uptake of mock- as well as CVB-infected Min6 cells. The reason for
efficient uptake of mock-infected Min6 cells is unknown, but could relate to enhanced
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molecular signals that mediate phagocytosis as previously discussed [34]. The differences in
uptake capacity of Min6 material by human DC subsets is in accordance with data from Tel
et al. who showed that BDCA1+ mDCs far more efficiently engulf particulate antigens com-
pared to other human DC subsets [41]. Of note, no direct linear correlation was observed be-
tween amount of virus-infected β-cell uptake and subsequent response; e.g. despite a lower
Fig 5. Induction of T cell proliferation and Th1 responses by BDCA1+ and BDCA3+ mDCs upon encounter of CVB-infected Min6 cells. A) DCs were
stimulated o/n as in Fig. 2A, harvested and co-cultured with allogeneic PBLs in 1:10 DC:PBL ratio. PBLs without DCs (PBL only) or PBLs stimulated with
phytohemagglutinin (PHA) were included as controls. Four days after start of co-culture proliferation was assessed using tritium incorporation. Cpm: counts
per minute.B) Supernatant taken 48 hours after start of co-culture as in A) was analyzed for production of indicated cytokines. Each symbol represents one
donor. * p<0.05, determined by ANOVA and post-hoc Tukey test.C) DCs were stimulated as in Fig. 2A, and 6 hours after stimulation mRNA expression was
determined by qPCR. *** p<0.001 determined by ANOVA and post-hoc Tukey test.D) DCs were stimulated o/n as in Fig. 2A and IL27 production was
assessed by ELISA. Each symbol represents one donor. Data are average of 2 independent experiments + SEM (A) or 2–4 donors from different
experiments (B, C, D).
doi:10.1371/journal.pone.0121670.g005
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uptake BDCA3+ DCs produce more type III IFNs and show equal type I IFN responses. Differ-
ent uptake mechanisms of cellular debris, different expression levels of PRRs and/or down-
stream signaling molecules, or a combination of both may cause strong BDCA3+ DC
activation, despite lower uptake. For example, higher expression levels of the double-stranded
RNA sensor TLR3 in BDCA3+ mDCs [28, 29] may cause differential downstream responses as
well as different synergistic responses in BDCA1+ and BDCA3+ mDC. Additionally, BDCA3+
mDCs may more specifically engulf “pathogen-associated material”, through expression of spe-
cialized uptake receptors like the C-type lectin CLEC9A [27, 42]. Importantly, regardless the
differences that may exist between BDCA1+ and BDCA3+ DC subsets in amount of uptake and
cargo selection, our data clearly show that both subsets induce distinct, but partially overlap-
ping antiviral responses.
In our current studies we used murine insulinoma cells to investigate the response of
human primary mDC subsets to CVB-infected β-cells. In our previous studies using moDC we
did not observe clear differences in the responses to infected murine Min6 cells, porcine islets
of Langerhans or human islets of Langerhans [34]. Nevertheless, analysis of the response of
fresh human DCs to infected human β-cells or primary human islets of Langerhans should
confirm our findings in future studies. The current experiments show clear DC-activation fol-
lowing uptake of Min6 cells. It remains to be determined to which extent the viral components
and the dead or dying cells themselves contribute to the observed responses. It is known that
virus-infected cells or apoptotic cells containing synthetic double-stranded RNA (dsRNA) lead
to strong DC activation, whereas apoptotic cells without dsRNA do not [43]. However, because
CVB-induced cell death results in release of endogenous ‘danger signals’ such as HMGB1 [44],
virus-induced cell death may contribute to the observed effects. Future experiments in which
cells are exposed to dead or dying cells not caused by virus infection should help to further elu-
cidate this issue.
BDCA1+ mDCs are considered the human counterparts of murine CD8α- DCs, which ac-
cording to previous studies are poor inducers of type I IFNs, and IL-12p70 and relatively poor
Th1 inducers [45]. This may, however, differ between mice and human, and could depend on
the particular stimulation. Our study reveals that upon encounter of enterovirus-infected β-
cells, BDCA1+ mDCs produce similar amounts of the type I IFN-α2 compared to BDCA3+
mDCs that are considered the human counterpart of murine CD8α+ DC. Furthermore, also
the extent of ISG induction is comparable between BDCA1+ and BDCA3+ mDCs, indicating
that both subsets can play a critical role in local anti-viral responses in vivo. Lauterbach and
colleagues [46] showed that especially BDCA3+ mDCs stimulated with the TLR-ligand poly I:C
produce IFN-λ1. Our data confirm these findings and show that BDCA3+ mDCs were also far
more efficient inducers of IFN-λ1 upon encounter with CVB-infected β-cells. Interestingly, a
recent study showed that islets of Langerhans are protected from enterovirus infection after
treatment with IFN-λ [47]. Whether and how IFN-λ influences autoimmune responses against
β-cells remains to be determined.
Our study revealed that upon encounter of virus-infected, but not mock-infected cells,
BDCA1+ mDCs showed higher induction of pro-inflammatory cytokines and chemokines
MIP-1α/CCL3, MIP-1β/CCL4 and MCP1/CCL2 compared to BDCA3+ mDCs, which is in ac-
cordance with findings from others [28]. One major difference between our results and those
of Hémont et al., is the absence of MCP-3/CCL7 in TLR-stimulated BDCA1+ and BDCA3+
mDC cultures in their studies, whereas for BDCA1+ mDCs we find that MCP-3 is induced to
modest extent upon poly I:C-stimulation, and is much stronger induced upon encounter of
CVB-infected cells. This shows that differential responses are induced upon encounter of puri-
fied TLR-ligands compared to the more physiological setting of encountering virus-infected
cells. Interestingly, MCP-3 expression is elevated in monocytes from type 1 diabetes patients
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compared to healthy donors or type 2 diabetes patients [48]; and MCP-3 is also elevated in
serum of autoantibody-positive individuals [49]; indicating a possibly pathological role for this
cytokine in autoimmune diabetes pathogenesis. The observation that BDCA1+ DCs are more
potent chemokines producers, whereas BDCA3+ DCs are superior in type III IFN production
suggests that besides overlapping functions, these mDC subsets do have more specialized func-
tions in e.g. chemoattraction of other immune cells versus induction of antiviral responses
through IFN-λ. Further in depth analysis is required to fully elucidate the complementary and
differential functions of human BDCA1+ mDCs, BDCA3+ mDCs and their cross-talk in (auto)
immunity.
Furthermore, IL-12p70 production was low/absent in BDCA3+ mDCs stimulated with ei-
ther poly I:C or CVB-infected cells. Similar observations were done by Jongbloed et al. and
Hémont et al. [28, 29]. Despite the much lower induction of IL12-p70 by BDCA3+ mDCs, they
induce Th1 responses (IFN-γ) and suppress Th2 responses (IL-5 and IL-13) equally well com-
pared to BDCA1+ mDCs under the conditions tested. Previous studies reported alternative IL-
12-independent mechanisms to achieve Th1 polarization [50–52], for example via the induc-
tion of type I IFNs [51]. Yet we did not find differences in IFN-α production between both
mDC subsets. Furthermore, no major differences between BDCA1+ and BDCA3+ mDCs were
observed in induction of IL-27, an IL-12 like cytokine with Th1 inducing capacities [38–40].
An alternative mechanism that could facilitate efficient Th1 induction in BDCA3+ MLR cul-
tures could be the ratio between co-stimulatory and co-inhibitory markers. The absence of
PD-L1 on BDCA3+ may steer towards Th1 phenotype in that case. Alternatively, the much
lower production of IL-10 by BDCA3+ mDCs may support Th1 skewing. Additionally, DCs
matured in the presence of IFN-λ induced lower IL-13 production and increased IFN-γ secre-
tion [53, 54]. Thus, the observed IFN-λ production in BDCA3+ mDCs could contribute to de-
creased Th2 cytokines and increased IFN-γ induction in our experiments. Furthermore, Poulin
et al. showed that BDCA3+ mDCs only produce IL-12 after CD40 ligation [55]. Thus, BDCA3+
mDCs in MLR cultures may produce IL-12 after CD40 ligation by T cells, resulting in en-
hanced Th1 induction. In summary, BDCA3+ mDCs are as efficient as BDCA1+ mDCs to in-
duce Th1 polarization, but employ a different mechanism that requires further in depth
analysis to elucidate.
The data presented yield valuable new insight into the physiological responses of freshly iso-
lated primary human blood DCs. The mDC subsets studied here can also be detected in differ-
ent human lymph nodes [56]. Despite the complexity of the experimental set up and the use of
human donors, similar trends are observed in essentially all donors. The data do, however, not
always reach statistical significance, mainly because the difference in the strength of the re-
sponses in the inherently variable human population. Nevertheless, the data clearly show that
DCs exposed to virus-infected, but not mock-infected β-cells give rise to potent Th1 responses.
These findings support the hypothesis that the co-presence of self-antigens in the virus infected
cells could result in initiation and/or acceleration of autoreactive responses by such activated
DCs in susceptible individuals [7, 8]. Additionally, whether and which differences exist be-
tween DC subsets from healthy donors and type 1 diabetes patients in the response enterovi-
rus-infected cells remains to be determined.
Supporting Information
S1 Fig. Gating strategy to analyze uptake and DC phenotype specifically in viable single
cells.
(TIF)
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S2 Fig. Appearance of Min6 cells 48 hours after infection.Magnification 40x.
(TIF)
S3 Fig. Confocal analysis of BDCA1+ DCs co-cultured with Min6 cells. DCs were co-
cultured with PKH67-labeled (green) mock- or CVB-infected Min6 cells for 18hrs and were
subsequently harvested, adhered onto poly-L-Lysine-coated coverslips, stained for MHC class
II (red) and DAPI (nuclear stain, blue) and analyzed using confocal laser scanning microscopy.
White arrows indicate examples of DCs that have phagocytosed Min6 material.
(TIF)
S4 Fig. No detection of human cytokines fromMin6 cultures.Min6 cells were mock- or
CVB-infected and after 18 hrs supernatant was harvested and analysed for indicated cytokines.
Supernatant from BDCA1+ DCs stimulated with poly I:C is shown as a positive control.
(TIF)
S5 Fig. mRNA induction of IFNgamma and reduction of IL-5 in MLR cultures from stimu-
lated BDCA1+ and BDCA3+ DCs.MLRs were performed as in Fig. 5A. After 48 hrs total
RNA was harvested as described and analyzed for expression of IFNgamma and IL-5.
(TIF)
S6 Fig. Production of IL-17 in MLR cultures of BDCA1 and BDCA3 DCs. Supernatant
taken 48 hours after start of co-culture as in Fig. 5A) was analyzed for production of IL-17A.
(TIF)
S7 Fig. No induction of EBI3 upon co-culture of DC subsets with mock- or CVB-infected
Min6 cells. DCs were stimulated as in Fig. 2A, and 6 hours after stimulation mRNA expression
was determined by qPCR.  p<0.001 determined by ANOVA and post-hoc Tukey test.
(TIF)
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